ConductScience.org, home

Paper35232007

Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.

Tang ASP and 19 others. Clin Mol Hepatol, 2022. Cited by 85 papers, by iCite.

Cite this record

ConductScience Library. Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals. Papers, record 35232007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35232007

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.
PubMed
Journal
Clin Mol Hepatol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Meta-Analysis
PubMed
Citations, by iCite
85
iCite
Relative citation ratio, by iCite
7.06
iCite
Revised in PubMed
2022-07-28
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tang ASPAnsel Shao Pin
2Chan KEKai En
3Quek JJingxuan
4Xiao JJieling
5Tay PPhoebe
6Teng MMargaret
7Lee KSKeng Siang
8Lin SYSnow Yunni
9Myint MZMay Zin
10Tan BBenjamin
11Sharma VKVijay K
12Tan DJHDarren Jun Hao
13Lim WHWen Hui
14Kaewdech AApichat
15Huang DDaniel
16Chew NWNicholas Ws
17Siddiqui MSMohammad Shadab
18Sanyal AJArun J
19Muthiah MMark
20Ng CHCheng Han

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiovascular DiseasesMajor topic
Carotid Artery DiseasesMajor topic
Ischemic StrokeMajor topic
Non-alcoholic Fatty Liver DiseaseMajor topic
Humans
Risk Factors

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in35730209Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?https://conductscience.org/library/papers/35730209

Source PubMed

Download CSV of comments and corrections

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118947828Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome.Atherosclerosis2009https://conductscience.org/library/papers/18947828PubMed
225603326Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.Rev Esp Enferm Dig2015https://conductscience.org/library/papers/25603326PubMed
327226159Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients.Sci Rep2016https://conductscience.org/library/papers/27226159PubMed
43802833Meta-analysis in clinical trials.Control Clin Trials1986https://conductscience.org/library/papers/3802833PubMed
532529110Diagnostic accuracy of carotid intima media thickness by B-mode ultrasonography in coronary artery disease patients.Arch Med Sci Atheroscler Dis2020https://conductscience.org/library/papers/32529110PubMed
624365733Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study.Korean J Gastroenterol2013https://conductscience.org/library/papers/24365733PubMed
728760353Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation.Clin Res Hepatol Gastroenterol2017https://conductscience.org/library/papers/28760353PubMed
824512497Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.J Clin Endocrinol Metab2014https://conductscience.org/library/papers/24512497PubMed
919824109Carotid lesions in outpatients with nonalcoholic fatty liver disease.World J Gastroenterol2009https://conductscience.org/library/papers/19824109PubMed
1034871813An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD.Clin Gastroenterol Hepatol2023https://conductscience.org/library/papers/34871813PubMed
1117218716What is heterogeneity and is it important?BMJ2007https://conductscience.org/library/papers/17218716PubMed
1233990287Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population.J Med Vasc2021https://conductscience.org/library/papers/33990287PubMed
1324904182Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography.Angiology2015https://conductscience.org/library/papers/24904182PubMed
1430945438Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions.Res Synth Methods2019https://conductscience.org/library/papers/30945438PubMed
1523085576Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease.Eur J Gastroenterol Hepatol2013https://conductscience.org/library/papers/23085576PubMed
1625197676The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence.Int J Health Policy Manag2014https://conductscience.org/library/papers/25197676PubMed
1725683387The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).Atherosclerosis2015https://conductscience.org/library/papers/25683387PubMed
1828395890Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.Am J Cardiol2017https://conductscience.org/library/papers/28395890PubMed
1923829707Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis.Ups J Med Sci2013https://conductscience.org/library/papers/23829707PubMed
2022748277Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.Atherosclerosis2012https://conductscience.org/library/papers/22748277PubMed

See all 102 referencesDownload CSV of references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.

PMIDTitleJournalYearIn PapersSource
42706037[Across-sectional study on the association between steatotic liver disease and its subtypes, cardiovascular health status, and extrahepatic comorbidity].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/42706037PubMed
42658392⁠From liver to cardiovascular system: the MASLD-ASCVD continuum.Intern Emerg Med2026https://conductscience.org/library/papers/42658392PubMed
41743673The association between liver disease and stroke risk: A cross-sectional study with machine learning in a large-scale Chinese cohort.Int J Cardiol Cardiovasc Risk Prev2026https://conductscience.org/library/papers/41743673PubMed
41634708Association of atherogenic index of plasma and cardiometabolic index with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018.Cardiovasc Diabetol2026https://conductscience.org/library/papers/41634708PubMed
41628974Influence of Metabolic Dysfunction-Associated Steatotic Liver Disease on Pattern and Management of Acute Coronary Syndrome.Saudi Med J2026https://conductscience.org/library/papers/41628974PubMed
41344054A roadmap to unveil the mechanism(s) of natural indole-derived molecules against NAFLD-derived HCC via systems pharmacology.Transl Oncol2026https://conductscience.org/library/papers/41344054PubMed
41225688Shengjiang Powder alleviates oxidative stress damage and fibrosis in mice with atherosclerosis concurrent with non-alcoholic fatty liver disease.Hereditas2025https://conductscience.org/library/papers/41225688PubMed
40990767Relationship between Liver Fibrosis Due to Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Atherosclerosis.Arq Bras Cardiol2025https://conductscience.org/library/papers/40990767PubMed
40868228Leukocyte Count Is Better than LDL-C as Predictor of Novel Carotid Atherosclerosis.Biomedicines2025https://conductscience.org/library/papers/40868228PubMed
40810106Attributable burden of steatotic liver disease on cardiovascular outcomes in Asia.JHEP Rep2025https://conductscience.org/library/papers/40810106PubMed
40332736Increased Hepatorenal Index Is Associated with the Risk of Developing Stroke in Patients with Nonalcoholic Fatty Liver Disease.Curr Med Sci2025https://conductscience.org/library/papers/40332736PubMed
40190413The effects of carotid plaque classification and bifurcation angle on plaque: a computational fluid dynamics simulation.Front Physiol2025https://conductscience.org/library/papers/40190413PubMed
40093193Mediating factors in the association between educational attainment and stroke: A mendelian randomization study.SSM Popul Health2025https://conductscience.org/library/papers/40093193PubMed
40050362Metabolic dysfunction-associated steatotic liver disease in adults.Nat Rev Dis Primers2025https://conductscience.org/library/papers/40050362PubMed
39838998Non-alcoholic fatty liver disease is a strong predictor of carotid high-risk plaques as assessed by high-resolution magnetic resonance imaging.Quant Imaging Med Surg2025https://conductscience.org/library/papers/39838998PubMed
39804409Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease.Curr Cardiol Rep2025https://conductscience.org/library/papers/39804409PubMed
39713133Non-obese non-alcoholic fatty liver disease and the risk of chronic kidney disease: a systematic review and meta-analysis.PeerJ2024https://conductscience.org/library/papers/39713133PubMed
39544247Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).J Clin Transl Hepatol2024https://conductscience.org/library/papers/39544247PubMed
39267090Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups.Cardiovasc Diabetol2024https://conductscience.org/library/papers/39267090PubMed
39234426Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis.Ther Adv Endocrinol Metab2024https://conductscience.org/library/papers/39234426PubMed

See all 49 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CIMT404677PubTator's text mininghttps://conductscience.org/library/genes/404677NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35232007

GET https://conductscience.org/api/papers/v1/35232007/references?page=2